FZD7 and chronic myelogenous leukemia, BCR-ABL1 positive: BMSCs from CML patients was shown to be more efficient to up-regulate FZD7/β-catenin siganling in CML cells than normal BMSCs, thus to accelerate proliferation, enhance IM resistance.